Risk factors for false positive and for false negative test results in screening with fecal occult blood testing

International Journal of Cancer

Volumn 133, Issue 10, 2013, Pages 2408-2414

  Stegeman, Inge ^a,b   De Wijkerslooth, Thomas R ^a   Stoop, Esther M ^c   Van Leerdam, Monique ^c   Van Ballegooijen, M ^c   Kraaijenhagen, Roderik A ^b   Fockens, Paul ^a   Kuipers, Ernst J ^c   Dekker, Evelien ^a   Bossuyt, Patrick M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NDDO Institute for Prevention and Early Diagnostics   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

colorectal cancer; false negative; false positive; fecal immunochemical test; prevention; screening

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVANCED CANCER; ARTICLE; ASYMPTOMATIC DISEASE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DRUG USE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FECAL IMMUNOCHEMICAL TEST; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCULT BLOOD TEST; PATIENT INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING;

COLORECTAL CANCER; FALSE NEGATIVE; FALSE POSITIVE; FECAL IMMUNOCHEMICAL TEST; PREVENTION; SCREENING;

CLINICAL LABORATORY TECHNIQUES; COLONOSCOPY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FECES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PILOT PROJECTS; RISK; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84883772616     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28242     Document Type: Article

References (37)

1. Dashwood RH,. Early detection and prevention of colorectal cancer (review). Oncol Rep 1999; 6: 277-81.
2. Winawer SJ, Sherlock P, Schottenfeld D, et al. Screening for colon cancer. Gastroenterology 1976; 70 (5 PT.1): 783-9.
3. de wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012; 107: 1570-8.
4. Mccann J, Stockton D, Godward S,. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res. 2002; 1-9.
5. Keyzer-Dekker CMG, van Esch L, de Vries J, et al. An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease. Breast Cancer Res Treat 2012; 134: 253-8.
6. Chiang T-H, Lee Y-C, Tu C-H, et al. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ 2011; 183: 1474-81.
7. de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. 2010: 1-9.
8. de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. BMC Gastroenterol 2010; 10: 47.
9. Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012; 13: 55-64.
10. Nagengast FM, Kaandorp CJ, CBO-werkgroep. [Revised CBO guideline "Follow-up after polypectomy"]. Ned Tijdschr Geneeskd 2001; 145: 2022-5.
11. Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290: 2959-67.
12. Butterworth AS, Higgins JP, Pharoah P,. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42: 216-27.
13. Anderson JC, Alpern Z, Sethi G, et al. Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol 2005; 100: 2049-55.
14. Betés M, Muñoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003; 98: 2648-54.
15. Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 2000; 11: 477-88.
16. Vogelaar I, van Ballegooijen M, Schrag D, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Cancer 2006; 107: 1624-33.
17. Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294: 914-23.
18. Chan AT, Giovannucci EL, Schernhammer ES, et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 2004; 140: 157-66.
19. Pietinen P, Malila N, Virtanen M, et al. Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 1999; 10: 387-96.
20. Raju R, Cruz-Correa M,. Chemoprevention of colorectal cancer. Dis Colon Rectum 2006; 49: 113-25.
21. Larsen IK, Grotmol T, Almendingen K, et al. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol 2006; 6: 5.
22. Samad, AK, Taylor RS, Marshall T, Chapman MA. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. 2005; 1-10.
23. Colkesen EB, Ferket BS, Tijssen JGP, et al. Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study. Vasc Health Risk Manag 2011; 7: 67-74.
24. van den Brink C, Ocke M, Houben A, et al. Validering van Standaardvraagstelling Voeding voor Lokale en National Monitor Volksgezondheid [Validation of a Community Health Services Food Consumption Questionnaire in the Netherlands]. Bilthoven, the Netherlands: Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2005.
25. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
26. Streiner DL,. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychiatry 2002; 47: 68-75.
27. Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087-91.
28. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Int Med 2003; 138: W1-12.
29. Smokers in the Netherlands [Internet]. Accessed on November 11, 2012. Available at: http://www.nationaalkompas.nl/gezondheidsdeterminanten/leefstijl/ roken/verschillen-internationaal/.
30. RIVM, ed. BMI, the Netherlands [Internet]. RIVM, Accessed on March 23, 2013. Available at: http://www.nationaalkompas.nl/gezondheidsdeterminanten/ persoonsgebonden/lichaamsgewicht/hoeveel-mensen-hebben-overgewicht-of- ondergewicht/.
31. van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; 101: 343-50.
32. Morikawa T, Kato J, Yamaji Y, et al. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol 2007; 102: 2259-64.
33. Kerlikowske K, Shepherd J, Creasman J, et al. Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst 2005; 97: 368-74.
34. Checka CM, Chun JE, Schnabel FR, et al. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 2012; 198: W292-5.
35. Pinsky RW, Helvie MA,. Mammographic breast density: effect on imaging and breast cancer risk. J Natl Compr Canc Netw 2010; 8: 1157-64-quiz1165.
36. Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006; 98: 1204-14.
37. Haug U, Knudsen AB, Kuntz KM,. How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis. Int J Cancer 2012; 131: 2094-102.